What does Dokriphar do?
Dokriphar is a pharmaceutical company that specializes in the development and production of generic medications. The company focuses on providing high-quality, cost-effective healthcare solutions to improve patient access to essential medicines. With a commitment to innovation and regulatory compliance, Dokriphar aims to enhance the overall health and well-being of communities worldwide.
- Activities
- Signals
-
High social debt vs. personnel costsHigh social debt vs. personnel costs 1,278.6%
Social debts are a high share of personnel costs, which may indicate social security arrears.
ProfitableProfitable € 121KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 2.83MStrong equity provides a buffer against setbacks.
Low riskLow risk 99.0%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 30.81A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 138KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 167KPositive EBITDA: operating activities are profitable.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
171K
|
€
240K
|
€
183K
|
€
152K
|
|
|
€
167K
|
€
236K
|
€
178K
|
€
128K
|
|
|
€
92K
|
€
136K
|
€
90K
|
€
63K
|
|
|
€
2.83M
|
€
2.82M
|
€
2.73M
|
€
2.64M
|
|
|
99.03%
|
98.63%
|
98.67%
|
98.25%
|
|
|
€
28K
|
€
39K
|
€
37K
|
€
47K
|
|
|
€
583K
|
€
598K
|
€
503K
|
€
389K
|
Publications 4
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Ontslagen - Benoemingen 05/12/2023
- Me. - Jaarrekening 30.06.2016, Ggk 02.12.2016, Ngl 20.12.2016 16708-0064-016 29/12/2016
- Me. - Jaarrekening 30.06.2015, Ggk 04.12.2015, Ngl 07.12.2015 15683-0469-016 15/12/2015
- Rubriek Oprichting (Nieuwe Rechtspersoon, Opening Bijkantoor, Enz...) 26/11/2013
Frequently asked questions
Answers to the most common questions about Dokriphar, based on official government data and the filed annual accounts.
What is the VAT number of Dokriphar?
The VAT number of Dokriphar is BE0541.871.001.
When was Dokriphar established?
Dokriphar was founded in 12-11-2013.
What is the official address of Dokriphar?
The official address of Dokriphar is Oudenaardegoed 14 Gent 9031.
What is the legal form of Dokriphar?
The juridical form of Dokriphar is Private limited company (BV/SRL).
What is the annual revenue of Dokriphar?
The 2025 accounts of Dokriphar do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Dokriphar do?
Dokriphar is a pharmaceutical company that specializes in the development and production of generic medications. The company focuses on providing high-quality, cost-effective healthcare solutions to improve patient access to essential medicines. With a commitment to innovation and regulatory compliance, Dokriphar aims to enhance the overall health and well-being of communities worldwide.
Is Dokriphar a reliable company?
Dokriphar is a registered Rechtspersoon with company number 0541.871.001 and can be verified through the official CBE database.
What is the credit limit of Dokriphar?
The estimated credit limit of Dokriphar is €300,692.
Is Dokriphar still active?
Dokriphar currently has the status "Normal situation" and is active.